Search by Drug Name or NDC
NDC 68180-0674-09 lurasidone hydrochloride 120 mg/1 Details
lurasidone hydrochloride 120 mg/1
lurasidone hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is LURASIDONE HYDROCHLORIDE.
MedlinePlus Drug Summary
Lurasidone is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in adults and children 13 years of age and older. It is also used to treat depression in adults and children 10 years of age and older with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lurasidone is also used along with lithium (Lithobid) or valproate (Depacon) to treat depression in adults with bipolar disorder. Lurasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Related Packages: 68180-0674-09Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Lurasidone
Product Information
| NDC | 68180-0674 |
|---|---|
| Product ID | 68180-674_e2ebb3d3-ad13-4700-b079-a4d98226ae99 |
| Associated GPIs | |
| GCN Sequence Number | 069894 |
| GCN Sequence Number Description | lurasidone HCl TABLET 120 MG ORAL |
| HIC3 | H7T |
| HIC3 Description | ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST |
| GCN | 33147 |
| HICL Sequence Number | 037321 |
| HICL Sequence Number Description | LURASIDONE HCL |
| Brand/Generic | Generic |
| Proprietary Name | lurasidone hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lurasidone hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 120 |
| Active Ingredient Units | mg/1 |
| Substance Name | LURASIDONE HYDROCHLORIDE |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Pharmaceutical Class | Atypical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA208031 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68180-0674-09 (68180067409)
| NDC Package Code | 68180-674-09 |
|---|---|
| Billing NDC | 68180067409 |
| Package | 90 TABLET in 1 BOTTLE (68180-674-09) |
| Marketing Start Date | 2023-01-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |